Correlation Between Premier Financial and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Premier Financial and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Premier Financial and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Premier Financial Corp and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Premier Financial and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Premier Financial with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Premier Financial and Lipella Pharmaceuticals.
Diversification Opportunities for Premier Financial and Lipella Pharmaceuticals
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Premier and Lipella is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Premier Financial Corp and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Premier Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Premier Financial Corp are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Premier Financial i.e., Premier Financial and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Premier Financial and Lipella Pharmaceuticals
Considering the 90-day investment horizon Premier Financial is expected to generate 1.91 times less return on investment than Lipella Pharmaceuticals. But when comparing it to its historical volatility, Premier Financial Corp is 2.88 times less risky than Lipella Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 327.00 in Lipella Pharmaceuticals Common on October 9, 2024 and sell it today you would earn a total of 30.00 from holding Lipella Pharmaceuticals Common or generate 9.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Premier Financial Corp vs. Lipella Pharmaceuticals Common
Performance |
Timeline |
Premier Financial Corp |
Lipella Pharmaceuticals |
Premier Financial and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Premier Financial and Lipella Pharmaceuticals
The main advantage of trading using opposite Premier Financial and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Premier Financial position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.Premier Financial vs. Bankwell Financial Group | Premier Financial vs. Middlefield Banc | Premier Financial vs. Civista Bancshares | Premier Financial vs. Primis Financial Corp |
Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |